0002104294-26-000002.txt : 20260121
0002104294-26-000002.hdr.sgml : 20260121
20260121161543
ACCESSION NUMBER: 0002104294-26-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20260121
DATE AS OF CHANGE: 20260121
EFFECTIVENESS DATE: 20260121
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRIGHTVIEW SENIOR LIVING IX-A, LP
CENTRAL INDEX KEY: 0002104294
ORGANIZATION NAME:
EIN: 413068324
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-570648
FILM NUMBER: 26547988
BUSINESS ADDRESS:
STREET 1: 218 NORTH CHARLES STREET, SUITE 220
CITY: BALTIMORE
STATE: MD
ZIP: 21201
BUSINESS PHONE: 888-566-8854
MAIL ADDRESS:
STREET 1: 218 NORTH CHARLES STREET, SUITE 220
CITY: BALTIMORE
STATE: MD
ZIP: 21201
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRIGHTVIEW SENIOR LIVING IX-B, LP
CENTRAL INDEX KEY: 0002104297
ORGANIZATION NAME:
EIN: 413044038
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-570648-01
FILM NUMBER: 26547989
BUSINESS ADDRESS:
STREET 1: 218 NORTH CHARLES STREET, SUITE 220
CITY: BALTIMORE
STATE: MD
ZIP: 21201
BUSINESS PHONE: 888-566-8854
MAIL ADDRESS:
STREET 1: 218 NORTH CHARLES STREET, SUITE 220
CITY: BALTIMORE
STATE: MD
ZIP: 21201
D
1
primary_doc.xml
X0708
D
LIVE
0002104294
BRIGHTVIEW SENIOR LIVING IX-A, LP
218 NORTH CHARLES STREET, SUITE 220
BALTIMORE
MD
MARYLAND
21201
888-566-8854
DELAWARE
None
None
Limited Partnership
true
2025
0002104297
BRIGHTVIEW SENIOR LIVING IX-B, LP
218 NORTH CHARLES STREET, SUITE 220
BALTIMORE
MD
MARYLAND
21201
888-566-8854
DELAWARE
None
None
Limited Partnership
true
2025
NA
Brightview Senior Living IX GP, LLC
218 NORTH CHARLES STREET SUITE 200
BALTIMORE
MD
MARYLAND
21201
Executive Officer
General Partner of Issuers.
NA
Brightview Senior Living Development, LLC
218 North Charles Street Suite 220
Baltimore
MD
MARYLAND
21201
Executive Officer
Managing Member of the Managing Member of the General Partner of the Issuers.
NA
Brightview Equities IX LLC
218 North Charles Street Suite 220
Baltimore
MD
MARYLAND
21201
Executive Officer
Managing Member of the General Partner of the Issuers.
Arnold
I
Richman
218 North Charles Street Suite 220
Baltimore
MD
MARYLAND
21201
Executive Officer
Co-Chairperson
Marilynn
K
Duker
218 North Charles Street Suite 220
Baltimore
MD
MARYLAND
21201
Executive Officer
Co-Chairperson
Doug
Dollenberg Jr
218 North Charles Street Suite 220
Baltimore
MD
MARYLAND
21201
Executive Officer
Chief Executive Officer/President
David
D
Carliner
218 North Charles Street Suite 220
Baltimore
MD
MARYLAND
21201
Executive Officer
Executive Vice President
Jeffrey
K
Hettleman
218 North Charles Street Suite 220
Baltimore
MD
MARYLAND
21201
Executive Officer
Executive Vice President
Brian
T
Engle
218 North Charles Street Suite 220
Baltimore
MD
MARYLAND
21201
Executive Officer
Executive Vice President/Secretary
Michael
Rodgers
218 North Charles Street Suite 220
Baltimore
MD
MARYLAND
21201
Executive Officer
Chief Financial Officer
Pooled Investment Fund
Other Investment Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
false
true
false
true
true
false
0
Shelter Rock Capital Group, LLC
156753
None
None
10 EAST 53RD STREET SUITE 1200
New York
NY
NEW YORK
10022
MA
MASSACHUSETTS
NY
NEW YORK
PA
PENNSYLVANIA
false
350000000
0
350000000
This offering is one of several offerings that comprise the Brightview Senior Living Fund IX. The total target offering amount for the Brightview Senior Living Fund IX is $350,000,000, subject to increase at the General Partner's discretion.
false
0
2420000
true
0
5600000
true
Management fee paid to General Partner of Issuers.
false
BRIGHTVIEW SENIOR LIVING IX-A, LP
Michael Rodgers
Michael Rodgers
CFO of Managing Member of Managing Member of GP
2026-01-21
BRIGHTVIEW SENIOR LIVING IX-B, LP
Michael Rodgers
Michael Rodgers
CFO of Managing Member of Managing Member of GP
2026-01-21